Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
FDA approves higher-dose version of Wegovy shots (feeds.feedburner.com)
2.
Strength persists after a mid-life course of obesity drugs (feeds.nature.com)
3.
Daily briefing: Hunter-gatherers in Europe’s ‘water world’ resisted the switch to farming for millennia (feeds.nature.com)
4.
The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs (feeds.nature.com)
5.
Girls are starting puberty younger — why, and what are the risks? (feeds.nature.com)
6.
Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight loss pill (cnbc.com)
7.
Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill (cnbc.com)
8.
The Wegovy Weight-Loss Pill Is Officially Here (gizmodo.com)
9.
The Wegovy Pill Is Officially Here (gizmodo.com)
10.
FDA Approves Pill Version of Wegovy (wired.com)
11.
Smartphones At Age 12 Linked To Worse Health (slashdot.org)
12.
Three rising stars in ageing research (feeds.nature.com)
13.
Trump unveils deal with Eli Lilly and Novo Nordisk to lower costs and expand coverage for obesity drugs (feeds.feedburner.com)
14.
American Obesity Rates Are Now Falling, and It’s Almost Certainly Because of Ozempic (futurism.com)
15.
A Staggering Number of Americans Are Now Considered Obese Under New Definition (gizmodo.com)
16.
Ozempic Maker Novo Nordisk Freezes Hiring Amid Ongoing Struggles (gizmodo.com)
17.
Diet, not lack of exercise, drives obesity, a new study finds (news.ycombinator.com)
18.
You can't outrun a bad diet (news.ycombinator.com)
19.
‘Extremely Severe’ Obesity in American Kids Is Surging, Study Finds (gizmodo.com)
20.
This Once-a-Month Ozempic Rival Just Delivered Big Results (gizmodo.com)
Today's top topics: cnet
View all today's topics →